Literature DB >> 10093629

How interested is the public in genetic testing for colon cancer susceptibility? Report of a cross-sectional population survey.

I D Graham1, D M Logan, R Hughes-Benzie, W K Evans, H Perras, L M McAuley, A Laupacis, H Stern.   

Abstract

OBJECTIVE: To assess the public's interest in genetic testing for colon cancer susceptibility, to determine whether provision of information about the accuracy of the test or the population risk of inheriting the colon cancer gene influences interest, to determine the reasons for wanting to be tested and to identify the factors related to interest in testing.
DESIGN: A cross-sectional random digit dialing telephone survey of 501 adults.
SETTING: Ontario. MAIN OUTCOME MEASURES: Proportion of the public interested in genetic testing; reasons for interest in testing.
RESULTS: Of the sample, 39.9% (95% confidence interval [CI] 35.5 to 44.3) stated that they would be very interested in taking a simple blood test if a positive result suggested they had an 80% chance of getting colon cancer sometime during their lifetime. When it was suggested that the test might be accurate only 90% of the time, 33.1% of the sample (95% CI 28.7 to 37.5) still said they would be very interested in testing. When informed that less than 1% of the population inherits the gene for colon cancer, the proportion of the sample stating they would still be very interested in genetic testing fell to 19.2% (95% CI 14.8 to 23.6). The main reasons given for wanting genetic testing were to take preventive action, for peace of mind and curiosity. For respondents who remained interested in testing after being given information about the population risk of inheriting the gene, 2 factors were identified by logistic regression analysis as being independently related to interest: worry about cancer and perceived risk of getting colon cancer.
CONCLUSIONS: If the public's interest in testing for colon cancer susceptibility has any influence on its eventual request to be tested, then demand for genetic testing may be considerable once such tests become widely available and known to the public. This study reveals that the public's interest in genetic testing is substantial, although modifiable by the provision of information about the population risk of inheriting a colon cancer gene. This finding suggests that genetic researchers and others should be careful to provide the population risk of inheriting cancer genes when discussing the discovery of these genes with the media. Furthermore, public health educators will need to ensure that information aids include material on familial risk criteria, genetic counselling and genetic testing, as well as on the implications of genetic testing, the general population risk of developing colon cancer and the general population risk of carrying the colon cancer gene. This information should also be provided to those who seek assessment, to health care professionals and to the public.

Entities:  

Mesh:

Year:  1998        PMID: 10093629

Source DB:  PubMed          Journal:  Cancer Prev Control        ISSN: 1206-548X


  8 in total

Review 1.  Challenges to the translation of genomic information into clinical practice and health policy: Utilization, preferences and economic value.

Authors:  Kathryn A Phillips; Su-Ying Liang; Stephanie Van Bebber
Journal:  Curr Opin Mol Ther       Date:  2008-06

Review 2.  Predictors of genetic testing decisions: a systematic review and critique of the literature.

Authors:  Kate Sweeny; Arezou Ghane; Angela M Legg; Ho Phi Huynh; Sara E Andrews
Journal:  J Genet Couns       Date:  2014-04-11       Impact factor: 2.537

3.  Value of Genetic Testing for Hereditary Colorectal Cancer in a Probability-Based US Online Sample.

Authors:  Sara J Knight; Ateesha F Mohamed; Deborah A Marshall; Uri Ladabaum; Kathryn A Phillips; Judith M E Walsh
Journal:  Med Decis Making       Date:  2015-01-14       Impact factor: 2.583

4.  The Impact of Test Outcome Certainty on Interest in Genetic Testing Among College Women.

Authors:  Lisa M Paglierani; Heidi J Kalkwarf; Susan L Rosenthal; Carl A Huether; Richard J Wenstrup
Journal:  J Genet Couns       Date:  2003-04       Impact factor: 2.537

5.  Preferences for genetic testing to identify hereditary colorectal cancer: perspectives of high-risk patients, community members, and clinicians.

Authors:  Judith Walsh; Millie Arora; Christina Hosenfeld; Uri Ladabaum; Miriam Kuppermann; Sara J Knight
Journal:  J Cancer Educ       Date:  2012-03       Impact factor: 2.037

6.  Men's values-based factors on prostate cancer risk genetic testing: a telephone survey.

Authors:  David J Doukas; Yuelin Li
Journal:  BMC Med Genet       Date:  2004-12-10       Impact factor: 2.103

7.  Interest in genomic SNP testing for prostate cancer risk: a pilot survey.

Authors:  Michael J Hall; Karen J Ruth; David Yt Chen; Laura M Gross; Veda N Giri
Journal:  Hered Cancer Clin Pract       Date:  2015-04-08       Impact factor: 2.857

8.  Public support for healthcare-mediated disclosure of hereditary cancer risk information: Results from a population-based survey in Sweden.

Authors:  Andreas Andersson; Carolina Hawranek; Anna Öfverholm; Hans Ehrencrona; Kalle Grill; Senada Hajdarevic; Beatrice Melin; Emma Tham; Barbro Numan Hellquist; Anna Rosén
Journal:  Hered Cancer Clin Pract       Date:  2020-09-15       Impact factor: 2.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.